FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078383428> ?p ?o ?g. }

• W2078383428 endingPage "e77S" @default.
• W2078383428 startingPage "e61S" @default.
• W2078383428 abstract "BackgroundContinued tobacco use in the setting of lung cancer management is frequently confounding and always of critical importance. We summarized the published literature concerning the management of tobacco dependence in patients with lung cancer and offer recommendations for integrating dependence treatment into ongoing oncologic care.MethodologyMEDLINE, Embase, CINAHL, PsychINFO, and the Cochrane Collaborative databases were searched for English language randomized clinical trials, cohort studies, case-control studies, secular trend analyses, and case series relevant to the a priori identified clinical questions. Evidence grading, integration, and genesis of recommendations followed the methods described in “Methodology for Development of Guidelines for Lung Cancer” in the American College of Chest Physicians Lung Cancer Guidelines, 3rd ed.ResultsWe describe the approach to tobacco dependence in patients with lung cancer at various phases in the evolution of cancer care. For example, among patients undergoing lung cancer screening procedures, we recommend against relying on the screening itself, including procedures accompanied solely by self-help materials, as an effective strategy for achieving abstinence. Among patients with lung cancer undergoing surgery, intensive perioperative cessation pharmacotherapy is recommended as a method for improving abstinence rates. Cessation pharmacotherapy is also recommended for patients undergoing chemotherapy, with specific recommendations to use bupropion when treating patients with lung cancer with depressive symptoms, as a means of improving abstinence rates, depressive symptoms, and quality of life.ConclusionsOptimal treatment of lung cancer includes attention to continued tobacco use, with abstinence contributing to improved patient-related outcomes at various phases of lung cancer management. Effective therapeutic interventions are available and are feasibly integrated into oncologic care. A number of important clinical questions remain poorly addressed by the existing evidence. CHEST 2013; 143(5)(Suppl):e61S–e77S Continued tobacco use in the setting of lung cancer management is frequently confounding and always of critical importance. We summarized the published literature concerning the management of tobacco dependence in patients with lung cancer and offer recommendations for integrating dependence treatment into ongoing oncologic care. MEDLINE, Embase, CINAHL, PsychINFO, and the Cochrane Collaborative databases were searched for English language randomized clinical trials, cohort studies, case-control studies, secular trend analyses, and case series relevant to the a priori identified clinical questions. Evidence grading, integration, and genesis of recommendations followed the methods described in “Methodology for Development of Guidelines for Lung Cancer” in the American College of Chest Physicians Lung Cancer Guidelines, 3rd ed. We describe the approach to tobacco dependence in patients with lung cancer at various phases in the evolution of cancer care. For example, among patients undergoing lung cancer screening procedures, we recommend against relying on the screening itself, including procedures accompanied solely by self-help materials, as an effective strategy for achieving abstinence. Among patients with lung cancer undergoing surgery, intensive perioperative cessation pharmacotherapy is recommended as a method for improving abstinence rates. Cessation pharmacotherapy is also recommended for patients undergoing chemotherapy, with specific recommendations to use bupropion when treating patients with lung cancer with depressive symptoms, as a means of improving abstinence rates, depressive symptoms, and quality of life. Optimal treatment of lung cancer includes attention to continued tobacco use, with abstinence contributing to improved patient-related outcomes at various phases of lung cancer management. Effective therapeutic interventions are available and are feasibly integrated into oncologic care. A number of important clinical questions remain poorly addressed by the existing evidence. CHEST 2013; 143(5)(Suppl):e61S–e77S" @default.
• W2078383428 created "2016-06-24" @default.
• W2078383428 creator A5009295952 @default.
• W2078383428 creator A5037072010 @default.
• W2078383428 creator A5037191310 @default.
• W2078383428 creator A5083872368 @default.
• W2078383428 date "2013-05-01" @default.
• W2078383428 modified "2023-09-26" @default.
• W2078383428 title "Treatment of Tobacco Use in Lung Cancer" @default.
• W2078383428 cites W1539687425 @default.
• W2078383428 cites W1836949740 @default.
• W2078383428 cites W1964263905 @default.
• W2078383428 cites W1967154481 @default.
• W2078383428 cites W1971882413 @default.
• W2078383428 cites W1978408088 @default.
• W2078383428 cites W1981378561 @default.
• W2078383428 cites W1987643081 @default.
• W2078383428 cites W1987935912 @default.
• W2078383428 cites W2000334667 @default.
• W2078383428 cites W2011541865 @default.
• W2078383428 cites W2012464780 @default.
• W2078383428 cites W2022331357 @default.
• W2078383428 cites W2022561165 @default.
• W2078383428 cites W2025741309 @default.
• W2078383428 cites W2028386819 @default.
• W2078383428 cites W2030283957 @default.
• W2078383428 cites W2034170061 @default.
• W2078383428 cites W2041727596 @default.
• W2078383428 cites W2043907370 @default.
• W2078383428 cites W2045028425 @default.
• W2078383428 cites W2045214274 @default.
• W2078383428 cites W2046514835 @default.
• W2078383428 cites W2051970071 @default.
• W2078383428 cites W2054315097 @default.
• W2078383428 cites W2064196353 @default.
• W2078383428 cites W2071691165 @default.
• W2078383428 cites W2073112219 @default.
• W2078383428 cites W2073387905 @default.
• W2078383428 cites W2075629149 @default.
• W2078383428 cites W2079460965 @default.
• W2078383428 cites W2079640934 @default.
• W2078383428 cites W2084289344 @default.
• W2078383428 cites W2084408370 @default.
• W2078383428 cites W2089816026 @default.
• W2078383428 cites W2091696918 @default.
• W2078383428 cites W2094697878 @default.
• W2078383428 cites W2096592736 @default.
• W2078383428 cites W2104609422 @default.
• W2078383428 cites W2106287038 @default.
• W2078383428 cites W2114554578 @default.
• W2078383428 cites W2125101578 @default.
• W2078383428 cites W2128409790 @default.
• W2078383428 cites W2129541348 @default.
• W2078383428 cites W2130797671 @default.
• W2078383428 cites W2138960985 @default.
• W2078383428 cites W2139911805 @default.
• W2078383428 cites W2139924423 @default.
• W2078383428 cites W2140760847 @default.
• W2078383428 cites W2141964792 @default.
• W2078383428 cites W2143951560 @default.
• W2078383428 cites W2144601861 @default.
• W2078383428 cites W2148636361 @default.
• W2078383428 cites W2152898426 @default.
• W2078383428 cites W2157815289 @default.
• W2078383428 cites W2158180864 @default.
• W2078383428 cites W2161819929 @default.
• W2078383428 cites W2171162252 @default.
• W2078383428 cites W2321633793 @default.
• W2078383428 cites W2417827962 @default.
• W2078383428 cites W4250513568 @default.
• W2078383428 doi "https://doi.org/10.1378/chest.12-2349" @default.
• W2078383428 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23649454" @default.
• W2078383428 hasPublicationYear "2013" @default.
• W2078383428 type Work @default.
• W2078383428 sameAs 2078383428 @default.
• W2078383428 citedByCount "42" @default.
• W2078383428 countsByYear W20783834282013 @default.
• W2078383428 countsByYear W20783834282014 @default.
• W2078383428 countsByYear W20783834282015 @default.
• W2078383428 countsByYear W20783834282016 @default.
• W2078383428 countsByYear W20783834282017 @default.
• W2078383428 countsByYear W20783834282018 @default.
• W2078383428 countsByYear W20783834282019 @default.
• W2078383428 countsByYear W20783834282020 @default.
• W2078383428 countsByYear W20783834282021 @default.
• W2078383428 countsByYear W20783834282022 @default.
• W2078383428 crossrefType "journal-article" @default.
• W2078383428 hasAuthorship W2078383428A5009295952 @default.
• W2078383428 hasAuthorship W2078383428A5037072010 @default.
• W2078383428 hasAuthorship W2078383428A5037191310 @default.
• W2078383428 hasAuthorship W2078383428A5083872368 @default.
• W2078383428 hasBestOaLocation W20783834281 @default.
• W2078383428 hasConcept C118552586 @default.
• W2078383428 hasConcept C121608353 @default.
• W2078383428 hasConcept C126322002 @default.
• W2078383428 hasConcept C142724271 @default.
• W2078383428 hasConcept C143998085 @default.
• W2078383428 hasConcept C177713679 @default.

• next